Sirolimus in Patients With Systemic Lupus Erythematosus-Associated Immune Thrombocytopenia

Abroad (travel likely)RecruitingPHASE2, PHASE3

Conditions

Systemic Lupus Erythematosus · Immune Thrombocytopenia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Peking Union Medical College Hospital, Beijing, Beijing Municipality, China
Contact: Study coordinator (Liying Peng) · liying_peng@qq.com

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

Systemic Lupus Erythematosus

Abroad (travel likely)RecruitingPHASE3

Avondale, United States · Chandler, United States

A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE Participants

Systemic Lupus Erythematosus (SLE) or Cutaneous Lupus Erythematosus

Abroad (travel likely)RecruitingPHASE1, PHASE2

La Palma, United States · Clearwater, United States

A Study of Obexelimab in Patients With Systemic Lupus Erythematosus

Systemic Lupus Erythematosus

Abroad (travel likely)RecruitingPHASE2

Fresno, United States · Huntington Park, United States

A Phase I Study to Assess LBL-047 in Healthy Adults and Patients With Systemic Lupus Erythematosus

Systemic Lupus Erythematosus

Abroad (travel likely)RecruitingPHASE1

Bengbu, China · Guangzhou, China